MPs scrutinize UGX 578 billion Pharma allocation
MPs on the Budget Committee of Parliament have questioned the idea of giving 578 billion shillings to DEI BioPharma Company, a private pharmaceutical company, to produce human drugs, since the government does not have shares in the company. This was during a meeting where the lawmakers were scrutinizing a 1.1 trillion supplementary budget that was requested by the Ministry of Finance to finance various programs in the FY 2023/2024, which ends in June.